Breaks Categories: Stock Spotlights

FridayFeb 02, 2018 11:46 am

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Aims to Double Revenue, Expand in 2018

Market analysis company ChineseInvestors.com (OTCQB: CIIX) has its sights set on making 2018 another successful year through remaining focused on key initiatives. An article discussing the company’s plans reads: “ChineseInvestors.com, Inc.’s (OTCQB: CIIX) mission is to become the leading publicly traded company targeting Chinese medicinal marijuana. Offering a variety of investor education products and services, Warren Wang, CEO and founder, would like to see 2018 bring with it double the revenue and expanded business. One of the ways CIIX is tackling this goal is through a Yelp-style app. Approved for download by the Apple App Store, this is the world’s…

Continue Reading

FridayFeb 02, 2018 11:40 am

CannabisNewsBreaks – Grey Cloak Tech, Inc.’s (GRCK) Eqova Life Sciences Provides Quality CBD Products

Last October, Grey Cloak Tech (OTCQB: GRCK) entered the CBD market sector through its acquisition of Eqova Life Sciences, an established producer of a wide range of clinical-grade hemp CBD oil products supplying medical practitioners. An article discussing the company reads: “Eqova’s products are not developed for recreational use, and the company only uses natural, standardized phytocannabinoid-rich hemp oil in its medical-grade, CBD-based products. It employs a rigorous product development cycle, where each ingredient is studied in isolation and in the context of other ingredients, use case and delivery method. Eqova has developed cutting-edge delivery methods for oral, topical, liposomal…

Continue Reading

TuesdayJan 30, 2018 11:23 am

CannabisNewsBreaks – Skinvisible, Inc.’s (SKVI) DermSafe Offers Long-term Protection Against H3N2 Flu Virus

Skinvisible’s (OTCQB: SKVI) innovative DermSafe product incorporates the company’s proprietary Invisicare® drug delivery technology and has proven effective against a variety of infectious germs. An article discussing the topical and transdermal product development company reads: “The main curse this season is the particularly malevolent influenza virus H3N2. It is the most dominant strain not only in the U.S. but in Canada and the UK. The virus, experts believe, is mainly transmitted through the air by droplets formed when infected persons cough, sneeze or talk. These droplets land on hard surfaces like door knobs and as soon as one touches it…

Continue Reading

MondayJan 29, 2018 11:38 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Potential to Lower Medication Doses Using Advanced Drug Delivery

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) has developed DehydraTECH™, a drug delivery platform that can be applied to various ingestible products such as foods, beverages, oral suspensions, tablets, capsules and more. An article discussing the company’s innovative drug delivery technology reads: “Lexaria’s DehydraTECH™ oral digestion technology is a ‘back office’ process that allows non-psychoactive cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and nicotine to be absorbed at much higher rates. The company has been working with the National Research Council of Canada (“NRC”), an agency of the Canadian federal government, to explore the effects of its technology. Lexaria’s superior delivery system…

Continue Reading

FridayJan 26, 2018 2:41 pm

CannabisNewsBreaks – Marijuana Company of America, Inc. (MCOA) Seasoned Leadership Results in Strong Market Presence

With a portfolio of operating subsidiaries, partnerships and joint ventures, Marijuana Company of America (OTC: MCOA) has established a strong presence in the industrial hemp CBD market. MCOA’s experienced leaders have strategically positioned the company in a flourishing market space. An article discussing the company’s strong market stance reads: “The company’s business model, and upper management’s experience, distinguishes MCOA from others in the sector. Donald Steinberg, MCOA’s CEO, is a cannabis industry pioneer. Along with MCOA director Charles Larsen, they founded the first marijuana company trading on a U.S. stock market, Medical Marijuana Inc. Together, their first-hand knowledge of the…

Continue Reading

FridayJan 26, 2018 2:31 pm

CannabisNewsBreaks – DOJA Cannabis Company Ltd. (CSE: DOJA) (OTC: DJACF) Aims to Multiply Production Capabilities in 2018

Premium cannabis lifestyle brand DOJA Cannabis Company (CSE: DOJA) (OTC: DJACF) is a licensed marijuana producer under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”). The company recently expanded its production capacity through the acquisition of a new warehouse. A recent article discussing the company reads: “As a licensed cannabis producer under the ACMPR through its wholly-owned subsidiary Northern Lights Marijuana Company, DOJA currently operates a 7,100-square-foot production facility that is licensed by Health Canada. The company recently acquired second facility is a 22,580-square-foot warehouse where its FUTURE LAB will be housed. The FUTURE LAB will be a state-of-the-art…

Continue Reading

FridayJan 26, 2018 11:04 am

CannabisNewsBreaks – Grey Cloak Tech, Inc. (GRCK) Offers Up-to-date Cannabis Information through CBD.co Marketplace

Grey Cloak Tech, Inc. (OTCQB: GRCK) is delivering current and wide-ranging information through its CBD online marketplace (www.CBD.co). The website offers users an entry into all things CBD and hemp oil. An article discussing the company’s online marketplace reads: “Through the marketplace, customers have access to purchase the company’s wide variety of CBD products, including oils, skincare soaps, balms and solutions, vapes and pet products. Transactions are secure, and the marketplace offers engaging and well-organized content, user-friendly navigation and added customer-centric enhanced capabilities with instant bot/messaging help.” To view the full article, visit http://cnw.fm/7PgHj About Grey Cloak Tech Inc. Grey…

Continue Reading

ThursdayJan 25, 2018 11:22 am

CannabisNewsBreaks – Skinvisible, Inc. (SKVI) to Enter Pain Management Therapeutics Market through Proposed Merger

Skinvisible (OTCQB: SKVI), a developer of innovative drug delivery technology, recently entered a Letter of Intent (“LOI”) regarding a proposed merger with Quoin Pharmaceuticals. The projected merger would mark the company’s entrance into the pain management therapeutics market. An article discussing the topical and transdermal product development company reads: “Skinvisible has a long, successful history developing and licensing Invisicare®, its patented polymer technology. Enhancing how drugs are delivered on, in, or through the skin, Invisicare® has proven efficacy in a wide range of dermatology and health care products, including products to treat acne, skin cancers, eczema, fungal infections, inflammation, warts…

Continue Reading

WednesdayJan 24, 2018 11:26 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Enhances Life by Uniting Nature and Science

An ongoing concern in North America, as reported by the Centers for Disease Control and Prevention, is that Americans are only taking advantage of preventive medical services about half as often as they should. Endeavoring to become a pioneer in preventative medicine, health science company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) was founded on the belief that, in healthcare, prevention is the best policy, and that nature and science can unite to offer a range of innovative, untapped solutions to address unmet clinical needs. As quoted in a recent article: “PreveCeutical is taking a new look at…

Continue Reading

WednesdayJan 24, 2018 11:19 am

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Platform Expands Portfolio

Food bioscience company Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) strategic focus for 2018 is on out-licensing its proprietary technology, DehydraTECH™. The company intends to out-license to third-party partners using a high margin royalty model. An article discussing the company’s drug delivery platform reads: “Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a research-driven company that has developed and out-licenses a patented drug delivery platform called DehydraTECH™ that changes the way active pharmaceutical ingredients (“APIs”) enter the body orally. According to a new report by Million Insights (http://cnw.fm/fGid9), the global API market is anticipated to reach $239.8 billion by 2025, with…

Continue Reading